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Activation of caspase-3 is generally acknowledged as a penultimate step in apoptotic cell death pathways.
Two studies in this issue of Cell Stem Cell (Fujita et al., 2008; Janzen et al., 2008) provide compelling data to
demonstrate that caspase-3 is also a conserved inductive cue for stem cell differentiation.Tissue development andmaintenance are
dependent on a complex interplay of stem
cell self-renewal, differentiation, and apo-
ptosis/programmed cell death. The phe-
notypic difference between renewal, dif-
ferentiation, and death implies that each
event is governed by a unique cohort
of factors. In this issue of Cell Stem Cell,
Fujita et al. (2008) and Janzen et al. (2008)
report that the key apoptotic protease,
caspase-3, mediates the differentiation
of embryonic stemcells (ESCs) and hema-
topoietic stem cells (HSCs), respectively.
Based on the premise that stem cell dif-
ferentiation corresponds with a loss of
self-renewal capacity, Fujita et al. (2008)
and Janzen et al. (2008) conducted a se-
ries of elegant studies to explore the role
of caspase-3 as a probable gatekeeper
of stem cell function. Using an inducible
caspase-3-specificcleavagesensor, Fujita
and colleagues observed that initiation of
caspase activity coincided with early
stages of ESC differentiation in otherwise
healthy cells. Further, caspase-3 null
ESCs displayed significant defects in
in vitro assays of differentiation as well as
an inability to form differentiated progeny
when transplanted in vivo. The authors
reasoned that caspase-3 mediated its
effects through targeted cleavage of a plu-
ripotent factor(s), demonstratingNanog to
be a priority target/substrate. Consistent
with this hypothesis, expression of a cas-
pase-3-resistant Nanog promoted ESC
self-renewal while inhibiting differentia-
tion. The results of Janzen et al. (2008)
were equally persuasive in linking cas-
pase-3 to the differentiation of HSC.Using
a null mouse model, the authors estab-
lished that loss of caspase-3 resulted
in the accumulation of phenotypicallydefined long-term (LT) repopulating HSCs,
with a corresponding reduction in circulat-
ing mature hematopoietic cells. In addi-
tion, no changes in the percent of apopto-
tic HSCs were observed. The observed
differentiation defect was shown to be
cell autonomous, as transplanted bone
marrow from caspase-3 null animals repli-
cated the aberrant hematopoietic lineage
profiles in wild-type recipient mice. Inter-
estingly, cytokine responsiveness and
cytokine-mediated signals were elevated
in caspase-3 null HSC, yet this alteration
did not appear to be dependent on the
enzymatic activity of the protease. To-
gether, these findings provide compelling
evidence that a protein with an estab-
lished apoptotic role is also indispensable
for the regulation of stemcell development
and differentiation.
The discovery of a nondeath role for
caspase-3 in stem cell self-renewal and
differentiation appears to be counterintui-
tive. For example, stem cells and their
immediate progeny need to remain free
of factors that can cause lasting cell dam-
age if they are to maintain pluripotency,
genome integrity, and LT survival. Typi-
cally, the activation of the proteolytic en-
zyme caspase-3 acts as a convergent
point for a number of death-signaling
pathways. Once engaged, the effecter
caspase enzymes, such as caspase-3, -6,
and -7, cleave vital protein substrates, an
event thatprecipitatesmanyof themorpho-
logic changes associated with cell death
(Fischer et al., 2003). Given the wealth of
observations that have positioned cas-
pase-3 as the arbiter of the death signal,
how is it then possible that this enzyme
could do anything other than kill a stem
cell?Cell StemThe answer to this question may arise
with a deeper appreciation of the me-
chanics that govern cell-fate decisions.
Indeed, while there exists an obvious
contradiction in the final outcomes of ap-
optosis and differentiation, there is also
a remarkable degree of morphologic and
biochemical symmetry between each
process. Cells undergoing either apopto-
sis or differentiation display comparable
cytoskeletal rearrangements, membrane
fusion, and fission events as well as simi-
lar alterations in chromatin and nuclear
architecture (Fernando and Megeney,
2007). This parallel is most evident in cells
that engage a differentiation phenotype
resembling attenuated cell death (i.e.,
are enucleated and short lived) such as
red blood cells and epithelial derivatives.
The differentiation program in these cell
lineages has been shown to be depen-
dent on a transient caspase-3 signal,
unlike the sustained caspase-activation
profile that triggers apoptosis (Ishizaki
et al., 1998; Zermati et al., 2001). Similarly,
transient activation of caspase-3 also
mediates differentiation of longer-lived
cell types such as skeletal muscle, osteo-
blasts, and neurons (Fernando et al.,
2002; Miura et al., 2004; Fernando and
Megeney, 2007). The observations from
the current studies greatly extend this
paradigm, suggesting that caspase-3-
directed differentiation is a primordial
feature of the cell-fate decision-making
process (Figure 1A).
The primary interpretation of Fujita et al.
(2008) and Janzen et al. (2008) is that cas-
pase-3 promotes stem cell differentiation
indirectly, by limiting self-renewal per se
rather than directly engaging a differentia-
tion program (Figure 1B). A corollary toCell 2, June 2008 ª2008 Elsevier Inc. 515
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(as-of-yet undefined) promote the stem
cell differentiation program following cas-
pase blockade of self-renewal. Data from
both studies demonstrate that caspase
inhibition leads to a dramatic increase in
the stem cell population, and Fujita and
colleagues have shown that caspase-3
limits ESC pluripotency through direct
cleavage of one protein alone, Nanog.
An alternative interpretation of the current
results may also be proposed. That is,
caspase-3 may participate in stem cell
differentiation in a more direct fashion
rather than by simply limiting self-renewal.
In this model, caspase-3 may simulta-
neously engage factors to promote the
gene expression profile and resulting phe-
notypic changes that result in a specific
differentiated cell type (Figure 1B). In po-
tential support of this hypothesis, Janzen516 Cell Stem Cell 2, June 2008 ª2008 Elsevand colleagues have shown that loss of
caspase-3 results in a dramatic reduction
in early B lymphocyte maturation, a step
far removed from the self-renewal process
of an HSC. This multitask interpretation is
also more consistent with previous obser-
vations that have demonstrated a direct
role for caspase-3 in the terminal differen-
tiation of numerous lineage-committed
cell types (as noted above). A definitive
position for either model will require
a more complete mapping of potential
caspase substrates.
Collectively, the work of Fujita et al.
(2008) and Janzen et al. (2008) suggests
that caspase-3 acts at multiple steps in
the stem cell life cycle, affecting both
self-renewal and differentiation. Yet, like
all exciting observations, the solution to
one mystery raises so many more ques-
tions. Paramount among these, how isier Inc.caspase-3 activity restrained and guided
to influence stem cell differentiation rather
than cell death? The study of cell differen-
tiation in other systems may provide the
answer. Drosophila spermatid differentia-
tion is dependent on the entire apoptotic
signal cascade that culminates in activa-
tion of caspase homologs (Huh et al.,
2004). However, caspase activity in this
system is tightly scripted through ubiqui-
tin-mediated degradation of caspase-
inhibitory proteins (Arama et al., 2007).
Such a mechanism ensures a level of
caspase activity that is sufficient to drive
spermatid differentiation yet not high
enough to engage an apoptotic program.
Whether this or other control mechanisms
operate in various mammalian stem cells
remains unknown.
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247–254.Figure 1. Caspase Regulation of Cell-Fate Decisions
(A) Caspase activation (green arrows) induces stem cell self-renewal, cell differentiation, or cell death
(apoptosis). The specific outcome may depend on the extent and/or kinetics of caspase activation.
(B) Fujita et al. (2008) and Janzen et al. (2008) postulate that caspase-3 indirectly promotes stem cell
differentiation by limiting self-renewal of the stem cell pool, hence favoring differentiation. Other, largely
unidentified, factors (depicted with blue arrows) are also likely to participate. Alternatively, caspase-3
may influence differentiation more directly, by actively engaging factors that promote the gene expression
and phenotype of a differentiated cell type, in addition to limiting self-renewal.
